INJECTION SITE MUSCLE WEAKNESS

INJECTION SITE MUSCLE WEAKNESS was reported 48 times

These drug classes are most commonly taken by patients reporting INJECTION SITE MUSCLE WEAKNESS:

# Drug Count
0 Acetylcholine Release Inhibitor [EPC] 15
1 Neuromuscular Blocker [EPC] 15
2 Interleukin-4 Receptor alpha Antagonist [EPC] 6
3 Atypical Antipsychotic [EPC] 5
4 Nonsteroidal Anti-inflammatory Drug [EPC] 5
5 5-alpha Reductase Inhibitor [EPC] 4
6 Aldosterone Antagonist [EPC] 4
7 Arteriolar Vasodilator [EPC] 4
8 Calcium Channel Blocker [EPC] 4
9 Dihydropyridine Calcium Channel Blocker [EPC] 4
10 HMG-CoA Reductase Inhibitor [EPC] 4
11 Vitamin B12 [EPC] 4
12 alpha-Adrenergic Blocker [EPC] 4
13 beta-Adrenergic Blocker [EPC] 4
14 Angiotensin Converting Enzyme Inhibitor [EPC] 3
15 CD20-directed Cytolytic Antibody [EPC] 3
16 Folate Analog Metabolic Inhibitor [EPC] 3
17 Histamine-1 Receptor Antagonist [EPC] 3
18 Opioid Agonist [EPC] 3
19 Proton Pump Inhibitor [EPC] 3
20 Vitamin C [EPC] 3
21 Vitamin D [EPC] 3
22 Calcium [EPC] 2
23 Mood Stabilizer [EPC] 2
24 Tumor Necrosis Factor Blocker [EPC] 2
25 Angiotensin 2 Receptor Blocker [EPC] 1
26 Anti-IgE [EPC] 1
27 Anti-epileptic Agent [EPC] 1
28 Calcitonin Gene-related Peptide Receptor Antagonist [EPC] 1
29 Central alpha-2 Adrenergic Agonist [EPC] 1
30 Corticosteroid [EPC] 1
31 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
32 Insulin Analog [EPC] 1
33 Interferon beta [EPC] 1
34 P2Y12 Platelet Inhibitor [EPC] 1
35 Platelet Aggregation Inhibitor [EPC] 1
36 Selective T Cell Costimulation Modulator [EPC] 1
37 Serotonin Reuptake Inhibitor [EPC] 1
38 Thymic Stromal Lymphopoietin Blocker [EPC] 1
39 beta3-Adrenergic Agonist [EPC] 1